David Einhorn Gain Therapeutics, Inc. Put Options Transaction History
Greenlight Capital Inc
- $1.97 Billion
- Q4 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
31Shares Held
3.75MCall Options Held
0Put Options Held
0-
Timelo Investment Management Inc.605KShares$653,7110.45% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$611,4200.04% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL450KShares$486,0000.0% of portfolio
-
Hohimer Wealth Management, LLC330KShares$356,4000.1% of portfolio
-
Geode Capital Management, LLC Boston, MA184KShares$198,4340.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $12.8M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...